Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05537389

Intravenous Neonatal Central Access Safety Trial

Conditions: Newborn Complication, Catheter Complications

Sex: All
Ages: 1 Hour – 3 Months
Healthy volunteers: No
Phase: NA
Enrollment: 768
Sponsor: University of Turin, Italy

Location: Città della Salute e della Scienza Torino Italia

Summary

Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICU). In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in neonates, remain to be demonstrated. In-line filters in the intravenous administration sets prevent the infusion of particles, which may reduce infectious complications.

Eligibility Criteria

Inclusion Criteria: * All patients admitted to NICU with at least one central venous catheter Exclusion Criteria: * Patients with peripheral venous catheter, patients with inflammatory episode at the time of enrollment

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05537389). StuddyBuddy aggregates publicly available trial information.